Newron Pharmaceuticals S.p.A.

Director's Dealing • Nov 27, 2025

News Details

Directors’ Dealings | 27 November 2025 15:10

Newron Pharmaceuticals S.p.A.: Luca Benatti, sell

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

27.11.2025 / 15:09 CET/CEST

The issuer is solely responsible for the content of this announcement.

---

1. Details of the person discharging managerial responsibilities / person closely associated

a) Name

Title:
First name:	Luca
Last name(s):	Benatti

2. Reason for the notification

a) Position / status

Position:	Member of the administrative or supervisory body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

Newron Pharmaceuticals S.p.A.

b) LEI

8156002F8C11F80A9740

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code

Type:	Share
ISIN:	IT0004147952

b) Nature of the transaction

Disposal
Transaction linked to the exercise of share option programmes

c) Price(s) and volume(s)

Price(s)	Volume(s)
17.0237118 CHF	247,984.41 CHF

d) Aggregated information

Price	Aggregated volume
17.0237 CHF	247,984.4100 CHF

e) Date of the transaction

26/11/2025; UTC+1

f) Place of the transaction

Name:	SIX Swiss Exchange
MIC:	XSWX

---

27.11.2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

View original content: EQS News

---

Language:	English
Company:	Newron Pharmaceuticals S.p.A.
	via Antonio Meucci 3
	20091 Bresso
	Italy
Internet:	www.newron.com

End of News	EQS News Service

---

102088  27.11.2025 CET/CEST